Prognostic Stage IV Breast Cancer AJCC v8 Completed Phase 1 / 2 Trials for Atezolizumab (DB11595)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03853707Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast CancerTreatment